Ciara Louise Freeman

31PUBLICATIONS

165CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targetsNaturopathy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (31)

Sort by Publication Date:

|Jul 08, 2026

Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

|Jun 11, 2026

Product-Intrinsic NF-κB-Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple Myeloma.

|Jan 21, 2026

Meaningful change in patient-reported outcomes after CAR-T for multiple myeloma: differences by race and ethnicity.

Laura B Oswald, Xiaoyin Li, Carina E Ferraris

|Oct 10, 2025

Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC/BCL2 rearrangements, DLBCL morphology.

Waleed Alduaij, Laurie H Sehn, Jean-Nicolas Champagne

|Sep 22, 2025

Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy.

Mark B Meads, Xiaohong Zhao, David Noyes

|Aug 01, 2025

Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy.

Binod Dhakal, Othman S Akhtar, David Fandrei

Pageof 6

Frequent Collaborators

10 joint publications

Taiga Nishihori

9 joint publications

Surbhi Sidana

8 joint publications

Diego Villa

8 joint publications

Omar Castaneda Puglianini

Kerry Joane Savage

Krina Patel

Alina S Gerrie

Pedro Farinha

David W Scott

Jeffrey W Craig

Frequent Collaborators

10 joint publications

Taiga Nishihori

9 joint publications

Surbhi Sidana

8 joint publications

Diego Villa

8 joint publications

Omar Castaneda Puglianini